175 related articles for article (PubMed ID: 29229837)
1. Early endosome as a pathogenic target for antiphosphatidylethanolamine antibodies.
Hou S; Fölsch H; Ke K; Cook Mills J; Ramsey-Goldman R; Zhao M
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13798-13803. PubMed ID: 29229837
[TBL] [Abstract][Full Text] [Related]
2. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
Hou S; Harper PE; Bardin N; Zhao M
J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome".
Sanmarco M
Autoimmun Rev; 2009 Dec; 9(2):90-2. PubMed ID: 19306951
[TBL] [Abstract][Full Text] [Related]
4. Is testing for antiphosphatidylethanolamine antibodies clinically useful?
Sanmarco M
Curr Rheumatol Rep; 2011 Feb; 13(1):81-5. PubMed ID: 21061099
[TBL] [Abstract][Full Text] [Related]
5. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
[TBL] [Abstract][Full Text] [Related]
6. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
Sanmarco M; Boffa MC
Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
[TBL] [Abstract][Full Text] [Related]
7. Seronegative antiphospholipid syndrome.
Nayfe R; Uthman I; Aoun J; Saad Aldin E; Merashli M; Khamashta MA
Rheumatology (Oxford); 2013 Aug; 52(8):1358-67. PubMed ID: 23502076
[TBL] [Abstract][Full Text] [Related]
8. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results.
Sanmarco M
J Immunol Methods; 2010 Jun; 358(1-2):9-16. PubMed ID: 20382150
[TBL] [Abstract][Full Text] [Related]
9. Seronegative Antiphospholipid Syndrome with Anti-phosphatidylethanolamine Antibody in a Boy.
Asano T; Narazaki H; Kaizu K; Kuwabara K; Fujino O; Itoh Y
J Nippon Med Sch; 2015; 82(2):117-20. PubMed ID: 25959205
[TBL] [Abstract][Full Text] [Related]
10. New autoantigens in the antiphospholipid syndrome.
Alessandri C; Conti F; Pendolino M; Mancini R; Valesini G
Autoimmun Rev; 2011 Aug; 10(10):609-16. PubMed ID: 21545849
[TBL] [Abstract][Full Text] [Related]
11. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
Mcintyre JA; Wagenknecht DR
J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
[TBL] [Abstract][Full Text] [Related]
12. [Central retinal vein occlusion and anti-phosphatidylethanolamine antibodies isolation: a case report].
Matonti F; Hoffart L; Trichet E; Conrath J; Ridings B
Can J Ophthalmol; 2010 Jun; 45(3):295-6. PubMed ID: 20379283
[No Abstract] [Full Text] [Related]
13. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
[TBL] [Abstract][Full Text] [Related]
14. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
[TBL] [Abstract][Full Text] [Related]
15. The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome.
Sanmarco M; Bardin N
Lupus; 2012 Jun; 21(7):727-8. PubMed ID: 22635214
[TBL] [Abstract][Full Text] [Related]
16. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.
Galve-de Rochemonteix B; Kobayashi T; Rosnoblet C; Lindsay M; Parton RG; Reber G; de Maistre E; Wahl D; Kruithof EK; Gruenberg J; de Moerloose P
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):563-74. PubMed ID: 10669657
[TBL] [Abstract][Full Text] [Related]
17. [Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?].
Yelnik CM; Dubucquoi S; Houfflin-Debarge V; Lambert M
Presse Med; 2015 Mar; 44(3):284-91. PubMed ID: 25542711
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
20. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome.
Staub HL; Bertolaccini ML; Khamashta MA
Autoimmun Rev; 2012 Dec; 12(2):230-4. PubMed ID: 22796282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
